18 May 2014
Russian Prime Minister Dmitry Medvedev entrusted Russian Ministry of Economic Development and Export Insurance Agency of Russia (EXIAR) to draft proposals on the support of exporters of domestic pharmaceutical and medical products.
Proprietary super drugs will land in Russia
18 May 2014
Head of the Russian Ministry of Health told that clinical development programs of novel drugs to combat lethal diseases are underway.
Russia to stand a good chance for leading positions in the biotech field - Medvedev
18 May 2014
Russia stands a chance to take leading positions in the biotech field, Russian Prime Minister Dmitry Medvedev reckons.
State to support exporters of medical and pharmaceutical products - Medvedev
17 May 2014
Russian Prime Minister Dmitry Medvedev entrusted the Russian Ministry of Economic Development and Trade to draft proposals on facilitation of Russian exporters of medical and pharmaceutical products through the Export Insurance Agency of Russia.
LA BioMed woos deep pockets interested in its lifesaving research
06 May 2014
From iodine eyedrops that prevent blindness in children to cholesterol testing to early discoveries that led to in vitro fertilization, the Los Angeles Biomedical Research Institute has made innovative scientific breakthroughs with worldwide implications since 1962.
Surgeon reports high patient satisfaction with hydrogel corneal inlay
06 May 2014
Overall patient satisfaction is 98% after implantation with the Raindrop inlay, according to a surgeon here.
Angel Investors Look At Biotech
05 May 2014
Angel groups are investing in biotech and are staying involved longer than ever before, creating new collaborations and financing options that raise more money than initial and subsequent rounds. Some say that today’s angels are similar to venture capitalists in the early 1990s.
Less is more for VCs investing in biotech
21 April 2014
Even in an off-quarter, biotech showed itself to be a key driver of New York's growing tech sector, and that momentum will need to continue in the face of stiff market headwinds.
New analysis incorporates real world insights from industry leaders
17 April 2014
Today the Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that outlines two potential growth trajectories for the U.S. biopharmaceutical sector and the top policy factors that enable the industry to innovate and, in turn, contribute to the U.S. economy.
PhRMA Report Reveals Growth Trajectories and Policy Factors Affecting Biopharmaceutical Growth
17 April 2014
The Pharmaceutical Research and Manufacturers of America (PhRMA) released a report that outlines two potential growth trajectories for the US biopharmaceutical sector. Developed by the Battelle Technology Partnership Practice, the report finds that coverage and payment policies, a science-based regulatory system, and strong intellectual property (IP) protections drive US leadership in biopharmaceutical innovation, and if negative trends in these key policy areas continue, jobs supported by the industry would decrease over the next decade.
Vaccination against the plague using a Russian drug is currently being carried out in Mongolia
24 July 2024
24 July 2024
Russia will conduct an experiment to block the supply of low-quality products to hospitals
23 July 2024
With seventh person seemingly cured of HIV, signs of hope for a broader cure
23 July 2024